EpiBiologics | $107,000,000 | (Jan 9, 2026)
Corsera Health | $80,000,000 | (Jan 9, 2026)
Oasys | $4,600,000 | (Jan 9, 2026)
Certified by Founder
Lodge
Flueid
start up
United States
- Austin, Texas
- 11/08/2023
- Series B
- $12,500,000
Flueid is a leading independent technology company fueling transactions with title data and intelligence to make them easily flow from start to finish. Our patented platform provides Verification of Title (VOT) solutions to real estate leaders to streamline the complete mortgage lending, title and closing, servicing and secondary markets processes.
- Industry Software Development
- Website https://www.flueid.com/?what%E2%80%99SNewAtFlueid%3F=1
- LinkedIn https://www.linkedin.com/company/flueid/
Vizgen | $48,000,000 | (Jan 9, 2026)
Poplar Therapeutics | $50,000,000 | (Jan 9, 2026)
Carna Health | $8,000,000 | (Jan 9, 2026)
Alveus Therapeutics Inc | $160,000,000 | (Jan 9, 2026)
AgileRL | $7,500,000 | (Jan 9, 2026)
Soley Therapeutics | $200,000,000 | (Jan 9, 2026)
SpangleAI | $15,000,000 | (Jan 9, 2026)
Presto Phoenix, Inc. | $10,000,000 | (Jan 9, 2026)
CHAMP | $55,000,000 | (Jan 7, 2026)